No abstract available
MeSH terms
-
Anticoagulants / adverse effects
-
Anticoagulants / blood
-
Anticoagulants / therapeutic use*
-
Benzimidazoles / blood
-
Benzimidazoles / therapeutic use
-
Dabigatran
-
Drug Monitoring*
-
Hemorrhage / chemically induced
-
Heparin / adverse effects
-
Heparin / blood
-
Heparin / therapeutic use
-
Humans
-
Morpholines / blood
-
Morpholines / therapeutic use
-
Pharmacovigilance*
-
Pyrazoles / blood
-
Pyrazoles / therapeutic use
-
Pyridones / blood
-
Pyridones / therapeutic use
-
Rivaroxaban
-
Thiophenes / blood
-
Thiophenes / therapeutic use
-
Thrombosis / chemically induced
-
Warfarin / adverse effects
-
Warfarin / blood
-
Warfarin / therapeutic use
-
beta-Alanine / analogs & derivatives
-
beta-Alanine / blood
-
beta-Alanine / therapeutic use
Substances
-
Anticoagulants
-
Benzimidazoles
-
Morpholines
-
Pyrazoles
-
Pyridones
-
Thiophenes
-
beta-Alanine
-
apixaban
-
Warfarin
-
Heparin
-
Rivaroxaban
-
Dabigatran